Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Intervalo de año de publicación
1.
Cells ; 13(7)2024 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-38607058

RESUMEN

During pregnancy, uterine vasculature undergoes significant circumferential growth to increase uterine blood flow, vital for the growing feto-placental unit. However, this process is often compromised in conditions like maternal high blood pressure, particularly in preeclampsia (PE), leading to fetal growth impairment. Currently, there is no cure for PE, partly due to the adverse effects of anti-hypertensive drugs on maternal and fetal health. This study aimed to investigate the vasodilator effect of extra virgin olive oil (EVOO) phenols on the reproductive vasculature, potentially benefiting both mother and fetus. Isolated uterine arteries (UAs) from pregnant rats were tested with EVOO phenols in a pressurized myograph. To elucidate the underlying mechanisms, additional experiments were conducted with specific inhibitors: L-NAME/L-NNA (10-4 M) for nitric oxide synthases, ODQ (10-5 M) for guanylate cyclase, Verapamil (10-5 M) for the L-type calcium channel, Ryanodine (10-5 M) + 2-APB (3 × 10-5 M) for ryanodine and the inositol triphosphate receptors, respectively, and Paxilline (10-5 M) for the large-conductance calcium-activated potassium channel. The results indicated that EVOO-phenols activate Ca2+ signaling pathways, generating nitric oxide, inducing vasodilation via cGMP and BKCa2+ signals in smooth muscle cells. This study suggests the potential use of EVOO phenols to prevent utero-placental blood flow restriction, offering a promising avenue for managing PE.


Asunto(s)
Calcio , Arteria Uterina , Ratas , Embarazo , Femenino , Animales , Arteria Uterina/metabolismo , Calcio/metabolismo , Aceite de Oliva/farmacología , Óxido Nítrico/metabolismo , Placenta/metabolismo , Rianodina , Fenoles/farmacología , Dilatación , Canales de Potasio de Gran Conductancia Activados por el Calcio/metabolismo , Endotelio/metabolismo
2.
Clin Exp Pharmacol Physiol ; 50(3): 256-263, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36440985

RESUMEN

Postoperative pain is one of the main negative symptoms resulting from surgery and the use of new methods to control this symptom is of ever-increasing relevance. Opioid-sparing strategies, such as multimodal analgesia, are trends in this scenario. Pregabalin is a well-established treatment for neuropathic pain; however, it is still controversial in the surgical context for postoperative analgesia. This study investigated the effect of pregabalin on postoperative analgesia in patients undergoing abdominal hysterectomy. It is a prospective, randomised, double-blind, placebo-controlled clinical trial. Female patients undergoing abdominal hysterectomy were randomised to use pregabalin (group P1), 300 mg orally 2 h before surgery, or identical placebo pills (group P0). The main outcome includes the postoperative pain index by visual analogue scale (VAS) and McGill's pain questionnaire. Secondary outcomes include opioid consumption and the presence of adverse effects. A value of p < 0.05 was used to reject type I error. Fifty-five patients were randomised amongst the groups. Patients in group P1 had lower pain rates by VAS scale, both at rest and in active motion, than group P0. In McGill's questionnaire, patients from group P1 also had lower pain rates (12 × 28.5). There was approximately twice as much opioid consumption amongst patients in group P0. Regarding side effects, there was a difference between the two groups only for dizziness, being more incident in group P1. This study suggests that pregabalin is an important adjuvant drug in treating postoperative pain in patients with abdominal hysterectomy.


Asunto(s)
Analgesia , Analgésicos Opioides , Humanos , Femenino , Pregabalina/uso terapéutico , Estudios Prospectivos , Analgésicos/uso terapéutico , Histerectomía/efectos adversos , Histerectomía/métodos , Dolor Postoperatorio/etiología , Dolor Postoperatorio/inducido químicamente , Método Doble Ciego
3.
Int J Mol Sci ; 23(11)2022 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-35682675

RESUMEN

Increasing levels of estrogens across gestation are partly responsible for the physiological adaptations of the maternal vasculature to pregnancy. The G protein-coupled estrogen receptor (GPER) mediates acute vasorelaxing effects in the uterine vasculature, which may contribute to the regulation of uteroplacental blood flow. The aim of this study was to investigate whether GPER expression and vasorelaxation may occur following pregnancy. Elucidation of the functional signalling involved was also investigated. Radial uterine and third-order mesenteric arteries were isolated from non-pregnant (NP) and pregnant rats (P). GPER mRNA levels were determined and-concentration-response curve to the GPER-specific agonist, G1 (10-10-10-6 M), was assessed in arteries pre-constricted with phenylephrine. In uterine arteries, GPER mRNA expression was significantly increased and vasorelaxation to G1 was significantly enhanced in P compared with NP rats. Meanwhile, in mesenteric arteries, there was a similar order of magnitude in NP and P rats. Inhibition of L-type calcium channels and extracellular signal-regulated kinases 1/2 significantly reduced vasorelaxation triggered by G1 in uterine arteries. Increased GPER expression and GPER-mediated vasorelaxation are associated with the advancement of gestation in uterine arteries. The modulation of GPER is exclusive to uterine arteries, thus suggesting a physiological contribution of GPER toward the regulation of uteroplacental blood flow during pregnancy.


Asunto(s)
Calcio/metabolismo , Receptores de Estrógenos , Arteria Uterina , Animales , Dilatación , Estrógenos/metabolismo , Femenino , Proteínas de Unión al GTP/metabolismo , Sistema de Señalización de MAP Quinasas , Embarazo , ARN Mensajero/metabolismo , Ratas , Receptores de Estrógenos/genética , Receptores de Estrógenos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Arteria Uterina/metabolismo , Vasodilatación
4.
Crit Rev Anal Chem ; 50(2): 111-124, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-30869528

RESUMEN

Corticosteroids are a class of hormones released by the adrenal cortex, which includes glucocorticoids and mineralocorticoids. Glucocorticoids have an important role in the metabolism of carbohydrates, proteins and calcium and effective anti-inflammatory and immunosuppressive activity. Due to their intense immunomodulatory and anti-inflammatory activity, glucocorticoids are used in the treatment of various inflammatory, malignant, allergic conditions such as rhinitis, asthma, dermatological, rheumatic, ophthalmic and neurological diseases, as well as after organ transplants. They are the most widely prescribed drugs in the world. The objective of this review is to provide an overview of the analytical methods in pharmaceutical matrices for determination of corticosteroids. In this study, the predominance of liquid chromatography methods for the analysis of corticosteroids from pharmaceutical products is evident for both liquid and semisolid dosage forms as well as for solids. The same can be said for topical, oral and parenteral formulations. Methods such as spectrophotometry are also used, but given the advantages of chromatographic methods such as better selectivity and sensitivity, they have become the choice for analysis of these drugs, however, most methods still do not meet the credentials of "green chemistry."


Asunto(s)
Corticoesteroides/análisis , Cromatografía Liquida , Humanos , Espectrofotometría
5.
Rev. bras. anal. clin ; 47(3): 110-112, 2015. graf
Artículo en Portugués | LILACS | ID: lil-775390

RESUMEN

Objetivo: Esse estudo visa comparar o desempenho do plasma humano com o plasma de coelho padronizado na técnica da coagulase livre para Diagnóstico de Staphylococcus aureus, verificando a viabilidade da Substituição. Métodos: Foi realizada a comparação do desempenho de ambos os plasmas colhidos com EDTA, através da prova da coagulase livre em tubo, utilizando 34 isolados de Staphylococcus aureus. Resultados: Dos 34 isolados de Staphylococcus aureus de amostras clínicas, todos (100%) coagularam o plasma de coelho e o plasma humano com Heparina e 15 (44%) coagularam o plasma humano com EDTA. Conclusão: Visto que o uso do plasma de coelho é o reagente padronizado para realização da prova da coagulase livre em tubo, na identificação de Staphylococcus aureus, os resultados obtidos indicam a possibilidade de substituição do plasma de coelho comercialmente disponível por plasma humano colhido com heparina, diminuindo os custos com esse procedimento laboratorial.


Asunto(s)
Humanos , Conejos , Coagulasa , Plasma , Conejos , Staphylococcus aureus
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA